Otilimab

DB06303InvestigationalProtein Based Therapies

Investigated for the treatment of osteoarthritis and rheumatoid arthritis (RA).

Mechanism: Pharmacologically active on Granulocyte-macrophage colony-stimulating factor
Curator reviewed
Primary indication: Investigated for use/treatment in inflammatory disorders (unspecified).Curator reviewed
Code names: GSK-3196165 · MOR-103

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Otilimab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.